Showing 6,006 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Neurological & cognitive problems

New predictors for peripheral neuropathy found in study of people living with HIV

News
6 July 2021
HIV treatment

Emtricitabine Factsheet

About HIV
July 2021
Bad science & bogus treatments

Hospitals across East Africa offer controversial anti-gay counselling

Editor's pick
OpenDemocracy
5 July 2021
Pharmaceutical industry

Gilead files long-acting HIV med for patients running out of options

Editor's pick
FierceBiotech
1 July 2021
Starting treatment

Starting HIV Treatment Is Personal, Not One-Size-Fits-All

Editor's pick
TheBody
1 July 2021
HIV treatment

Lamivudine Factsheet

About HIV
June 2021
Pharmaceutical industry

GSK puts long-acting injectables at heart of HIV growth plans, downplays threat of oral rival from Gilead and Merck

Editor's pick
FiercePharma
29 June 2021
Weight gain & lipodystrophy

Strategies for Managing Weight Gain in HIV Patients

Editor's pick
Infectious Disease Special Edition
29 June 2021
New & experimental HIV treatments

Gilead Submits New Drug Application to U.S. Food and Drug Administration for Lenacapavir, an Investigational, Long-Acting Capsid Inhibitor for the Treatment of HIV-1 in People With Limited Therapy Options

Editor's pick
Gilead press release
29 June 2021
HIV treatment

Efavirenz Factsheet

About HIV
June 2021
Treatment outcomes & life expectancy

Spanish studies highlight scale of late presentation and its consequences for treatment

News
24 June 2021
Side effects

Side effects Illustrated

About HIV
June 2021
Injectable & long-acting HIV treatment

GSK's ViiV, under threat from Gilead-Merck collab, eyes 'ultra-long-acting' HIV drugs with Halozyme deal

Editor's pick
FiercePharma
23 June 2021
Injectable & long-acting HIV treatment

Long-acting Injectables: when will they be available in the UK?

Editor's pick
UK-CAB
21 June 2021
Treatment guidelines

What's New in U.S. HIV Clinical Treatment Guidelines

Editor's pick
TheBodyPro
17 June 2021
Liver disease

HIV treatment choice affects improvement in liver after hepatitis C cure

News
14 June 2021
Retention & linkage to care

Study Supports Importance of Patient Agency, Stability in HIV Treatment

Editor's pick
American Journal of Managed Care
8 June 2021
Resistance

Injectable HIV therapy should only be given after a check for innate resistance, French study suggests

News
8 June 2021
Treatment guidelines

Updates to the Antiretroviral Agents in Adults and Adolescents Living with HIV Guidelines Released

Editor's pick
HIV.gov
7 June 2021
Bad science & bogus treatments

Popular Nigerian televangelist T.B. Joshua dies at 57

Editor's pick
Deutsche Welle
7 June 2021
Money

Immediate HIV treatment reduces out-of-pocket health expenditures

News
4 June 2021
Weight gain & lipodystrophy

Weight gain after changing treatment more likely when switching from efavirenz or old-style tenofovir

News
2 June 2021
Sexual health

Delayed HIV treatment initiation and protease inhibitors associated with erectile dysfunction in men living with HIV

News
31 May 2021
Injectable & long-acting HIV treatment

Long-Acting ART Rollout: 3 Considerations for Clinicians

Editor's pick
TheBodyPro
26 May 2021